Gemini Therapeutics, Inc. ($GMTX)
Filing Information
| Accession Number | 0001193125-26-059760 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
11,156
Total Value
$719,727.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Feb 17, 2026 | Sale | 4,075 | $62.86 | $256,154.50 | 78,424 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 18, 2026 | Sale | 3,397 | $65.01 | $220,837.95 | 75,027 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 18, 2026 | Sale | 3,684 | $65.89 | $242,734.71 | 71,343 | Direct | โ | View Details |